Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Aug;79(2):383-9.
doi: 10.1086/505885. Epub 2006 Jun 5.

Sequencing of the reannotated LMNB2 gene reveals novel mutations in patients with acquired partial lipodystrophy

Affiliations

Sequencing of the reannotated LMNB2 gene reveals novel mutations in patients with acquired partial lipodystrophy

Robert A Hegele et al. Am J Hum Genet. 2006 Aug.

Abstract

The etiology of acquired partial lipodystrophy (APL, also called "Barraquer-Simons syndrome") is unknown. Genomic DNA mutations affecting the nuclear lamina protein lamin A cause inherited partial lipodystrophy but are not found in patients with APL. Because it also encodes a nuclear lamina protein (lamin B2) and its genomic structure was recently reannotated, we sequenced LMNB2 as a candidate gene in nine white patients with APL. In four patients, we found three new rare mutations in LMNB2: intron 1 -6G-->T, exon 5 c.643G-->A (p.R215Q; in two patients), and exon 8 c.1218G-->A (p.A407T). The combined frequency of these mutations was 0.222 in the patients with APL, compared with 0.0018 in a multiethnic control sample of 1,100 subjects (P = 2.1 x 10-7) and 0.0045 in a sample of 330 white controls (P = 1.2 x 10-5). These novel heterozygous mutations are the first reported for LMNB2, are the first reported among patients with APL, and indicate how sequencing of a reannotated candidate gene can reveal new disease-associated mutations.

PubMed Disclaimer

Figures

Figure  1.
Figure 1.
A, Genomic structure of LMNB2 as it was known in 2001 and 2005 (with respective reference sequence numbers indicated). Boxes indicate exons, with the exon number shown above. B, Electropherogram tracings of genomic DNA sequences of the LMNB2 gene from healthy control subjects (top row of sequences) and subjects with APL (lower row of sequences). Normal genomic sequence for each region is shown above the tracings, in addition to 5′ and 3′ orientation. Mutation names are given below the tracings, with arrows pointing to mutant heterozygous sequences. The sequence designated c.82G→A in exon 1 was later determined to be a polymorphism that was seen at relatively high frequency in control subjects of several ethnic backgrounds and was not significantly associated with APL in this sample. C, Schematic diagram of head, rod, and tail domains of lamins B2 and A. Subdomains of the rod domain are shown as numbered coil domains and numbered “linker” domains (L). The numbers of amino acid residues for each region of each lamin type are shown in parentheses above the domain maps. The positions of the two LMNB2 missense mutations are shown (arrows). For the p.R215Q mutation within Coil 1B of the highly conserved rod domain, the homologous regions from lamins B2, A, and B1 are shown below the map, with the respective amino acid numbers on each side of this conserved region. R215 in lamin B2 and the corresponding residue in the other lamins are boxed.

Similar articles

Cited by

References

Web Resources

    1. GenBank, http://www.ncbi.nlm.nih.gov/Genbank/ (for LMNB2 2001 reference sequence [accession numbers M94362 and M94363] and 2005 reference sequence [accession numbers NT_011255 and NM_032737])
    1. Online Mendelian Inheritance in Man (OMIM), http://www.ncbi.nlm.nih.gov/Omim/ (for LMNA, APL, FPLD2, LMNB2, CGL, FPLD3, Emery-Dreifuss muscular dystrophy, Pelger-Huet anomaly, and hydrops-ectopic calcification-moth-eaten skeletal dysplasia)

References

    1. Garg A (2004) Acquired and inherited lipodystrophies. N Engl J Med 350:1220–123410.1056/NEJMra025261 - DOI - PubMed
    1. Hegele RA (2004) Phenomics, lipodystrophy, and the metabolic syndrome. Trends Cardiovasc Med 14:133–13710.1016/j.tcm.2004.02.001 - DOI - PubMed
    1. Capeau J, Magre J, Lascols O, Caron M, Bereziat V, Vigouroux C, Bastard JP (2005) Diseases of adipose tissue: genetic and acquired lipodystrophies. Biochem Soc Trans 33:1073–107710.1042/BST20051073 - DOI - PubMed
    1. Hegele RA (2005) Lessons from human mutations in PPARγ. Int J Obes (Lond) Suppl 1 29:S31–S35 - PubMed
    1. Misra A, Garg A (2003) Clinical features and metabolic derangements in acquired generalized lipodystrophy: case reports and review of the literature. Medicine (Baltimore) 82:129–146 - PubMed

Publication types

LinkOut - more resources